accountaccused of 400 percent price hike for HIV drug By Dan Levine OAKLAND, Calif., March 24 (Reuters) - Abbott Laboratories (ABT.N Closing arguments began on Thursday in a case in which Abbott is accused by GlaxoSmithKline of anti-competitive behavior...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Glaxo lawyer says Abbott used HIV drug as weapon
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account